ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

CDNA vs CELC // OPERATING MARGIN

CareDx Inc. (NASDAQ) VS. Celcuity Inc. (NASDAQ) • 15-METRIC TALLY: CDNA 5 — CELC 0
■ METRIC PARITY
operating-margins
-8.10%
operating-margins
—
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (CDNA VS. CELC) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC CDNA CELC SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin — — — TIE /gross-margins <GO>
Return on Invested Capital (ROIC) -8.20% -35.00% +26.80 CDNA /roic <GO>
EV/EBITDA & P/E Valuation — — — TIE /valuation <GO>
Free Cash Flow Yield 0.67% -4.53% +5.20 CDNA /fcf-yield <GO>
Operating Margin ACTIVE -8.10% — — TIE /operating-margins <GO>
Net Profit Margin -5.60% — — TIE /net-margins <GO>
Revenue Growth (YoY) 13.80% — — TIE /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 0.00% 0.00 TIE /dividend-safety <GO>
Altman Z-Score & Debt/Equity 19.22 — — TIE /balance-sheet <GO>
Piotroski F-Score Quality 7/9 2/9 +5.00 CDNA /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 54.9 49.3 +5.61 CDNA /rsi-technicals <GO>
10Y Yield & FRED Macro Beta 1.06 — — TIE /macro-sensitivity <GO>
Forward P/E Multiple 21.0x — — TIE /forward-pe <GO>
Enterprise Scale & Market Cap $3.70B $3.39B $309.1M CDNA /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR CDNA REV CELC REV CDNA GROSS % CELC GROSS % CDNA FCF CELC FCF
FY 2025 $379.8M $0 — — $24.9M -$153.5M
FY 2024 $333.8M $0 — — $23.0M -$83.7M
FY 2023 $280.3M $0 — — -$31.0M -$53.8M
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
CDNA // BETA 1.06
CELC // BETA —